Articles dans des revues avec comité de lecture (48)
  1. 36. Reeff, J., Gaignaux, A., Goole, J., De Vriese, C., & Amighi, K. (2012). New sustained-release intraarticular gel formulations based on monolein for local treatment of arthritic diseases. Drug development and industrial pharmacy. doi:10.3109/03639045.2012.730529
  2. 37. Duret, C., Wauthoz, N., Merlos, R., Goole, J., Maris, C., Roland, I., Sebti, T., Vanderbist, F., & Amighi, K. (2012). In vitro and in vivo evaluation of a dry powder endotracheal insufflator device for use in dose-dependent preclinical studies in mice. European journal of pharmaceutics and biopharmaceutics, 81(3), 627-634. doi:10.1016/j.ejpb.2012.04.004
  3. 38. Gaignaux, A., Reeff, J., Siepmann, F., Siepmann, J., De Vriese, C., Goole, J., & Amighi, K. (2012). Development and evaluation of sustained-release clonidine-loaded PLGA microparticles. International journal of pharmaceutics, 437(1-2), 20-28. doi:10.1016/j.ijpharm.2012.08.006
  4. 39. Goole, J., Lindley, D. J., Roth, W., Carl, S. M., Amighi, K., Kauffmann, J.-M., & Knipp, G. T. (2010). The effects of excipients on transporter mediated absorption. International journal of pharmaceutics, 393(1-2), 17-31. doi:10.1016/j.ijpharm.2010.04.019
  5. 40. Amighi, K., & Goole, J. (2009). Levodopa delivery systems for the treatment of Parkinson's disease: an overview. International journal of pharmaceutics, 380(1-2), 1-15. doi:10.1016/j.ijpharm.2009.07.026
  6. 41. Goole, J., Van Gansbeke, B., Pilcer, G., Deleuze, P., Blocklet, D., Goldman, S., Pandolfo, M., Vanderbist, F., & Amighi, K. (2008). Pharmacoscintigraphic and pharmacokinetic evaluation on healthy human volunteers of sustained-release floating minitablets containing levodopa and carbidopa. International journal of pharmaceutics, 364(1), 54-63. doi:10.1016/j.ijpharm.2008.08.016
  7. 42. Goole, J., Amighi, K., & Vanderbist, F. (2008). Evaluation and floating enhancement of levodopa sustained release floating minitablets coated with insoluble acrylic polymer. Drug development and industrial pharmacy, 34(8), 827-833. doi:10.1080/03639040801926683
  8. 43. Goole, J., Vanderbist, F., & Amighi, K. (2008). In vitro evaluation of two concepts of sustained release floating minitablets according to the model drug used. Journal of drug delivery science and technology, 18(2), 133-138.
  9. 44. Goole, J., Deleuze, P., Vanderbist, F., & Amighi, K. (2008). New levodopa sustained-release floating minitablets coated with insoluble acrylic polymer. European journal of pharmaceutics and biopharmaceutics, 68(2), 310-318. doi:10.1016/j.ejpb.2007.06.017
  10. 45. Pilcer, G., Goole, J., Van Gansbeke, B., Blocklet, D., Knoop, C., Vanderbist, F., & Amighi, K. (2008). Pharmacoscintigraphic and pharmacokinetic evaluation of tobramycin DPI formulations in cystic fibrosis patients. European journal of pharmaceutics and biopharmaceutics, 68(2), 413-421. doi:10.1016/j.ejpb.2007.05.005
  11. 46. Goole, J., Vanderbist, F., & Amighi, K. (2007). Development and evaluation of new multiple-unit levodopa sustained-release floating dosage forms. International journal of pharmaceutics, 334(1-2), 35-41. doi:10.1016/j.ijpharm.2006.10.018
  12. 47. Hamdani, J., Goole, J., Moës, A., & Amighi, K. (2006). In vitro and in vivo evaluation of floating riboflavin pellets developed using the melt pelletization process. International journal of pharmaceutics, 323(1-2), 86-92. doi:10.1016/j.ijpharm.2006.05.056
    13. << Précédent 1 2 3 4 5 6 7 8 9 10 Suivant >>